We therefore conclude that "gut microbiota – SCFAs – GPR41/43" is involved in the pathological process of T2DM, and this finding may provide a new strategy for the treatment of diabetes and a new direction for the research and development of new hypoglycemic drugs. The gene discussed is FFAR3; the disease is type 2 diabetes mellitus.